Pharma & Biotech

Tempest Therapeutics experienced a significant selloff after revealing plans for a substantial capital raise. The clinical-stage biotechnology company saw its...

After a period of consolidation, Viking Therapeutics stock may be entering another phase of volatility. The biotech firm has scheduled...

Eli Lilly has entered the financial record books by becoming the first pharmaceutical company to achieve a market capitalization exceeding...

Canadian regulatory authorities have launched an investigation into WELL Health Technologies, a strategic partner and major shareholder of Healwell AI,...

Biotechnology firm Ocugen finds itself navigating contrasting currents as its shares trade under technical pressure around €1.05 while management outlines...

PepsiCo, the beverage and snack food titan headquartered in Purchase, New York, is confronting an emerging market challenge that few...

The markets are behaving in a manner that defies conventional wisdom regarding InnoCan Pharma. Typically, significant positive developments propel a...

Danish pharmaceutical giant Novo Nordisk faces a significant strategic challenge following the disappointing outcome of its highly anticipated Alzheimer's treatment...

A prolonged period of negotiations and strategic maneuvering within the German biotech sector has culminated in a definitive resolution. Shareholders...

Halozyme Therapeutics finds itself at a pivotal moment as it navigates a significant executive transition against a backdrop of exceptional...